×
About 109,826 results

ALLMedicine™ Squamous Cell Carcinoma Center

Research & Reviews  53,851 results

ACR Appropriateness Criteria® Staging and Follow-up of Vulvar Cancer.
https://doi.org/10.1016/j.jacr.2021.02.016
Journal of the American College of Radiology : JACR; , Lakhman Y et. al.

May 7th, 2021 - Vulvar cancer is an uncommon gynecologic tumor and one of several human papillomavirus-associated malignancies. Squamous cell carcinoma is the most prevalent histologic subtype of vulvar cancer, accounting for the majority of cases. Imaging plays ...

Predicting survival in head and neck cancer: External validation and update of the prog...
https://doi.org/10.1002/hed.26716
Head & Neck; Hoesseini A, van Leeuwen N et. al.

May 7th, 2021 - Disclosing prognostic information is necessary to enable patients to make well-informed treatment decisions. OncologIQ is a prognostic model that predicts the overall survival (OS) probability in patients with head and neck squamous cell carcinoma...

Radiomics and gene expression profile to characterise the disease and predict outcome i...
https://doi.org/10.1007/s00259-021-05371-7
European Journal of Nuclear Medicine and Molecular Imaging; Kirienko M, Sollini M et. al.

May 7th, 2021 - The objectives of our study were to assess the association of radiomic and genomic data with histology and patient outcome in non-small cell lung cancer (NSCLC). In this retrospective single-centre observational study, we selected 151 surgically t...

Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry ...
https://doi.org/10.1002/cam4.3909
Cancer Medicine; Jani KS, Lu SE et. al.

May 7th, 2021 - Increased risk of a second primary malignancy (SPM) before or after diagnosis of anal squamous cell carcinoma (ASCC) has been reported in a previous single-institution study. We hypothesize that patients diagnosed with ASCC are at increased risk f...

see more →

Guidelines  137 results

ACR Appropriateness Criteria® Staging and Follow-up of Vulvar Cancer.
https://doi.org/10.1016/j.jacr.2021.02.016
Journal of the American College of Radiology : JACR; , Lakhman Y et. al.

May 7th, 2021 - Vulvar cancer is an uncommon gynecologic tumor and one of several human papillomavirus-associated malignancies. Squamous cell carcinoma is the most prevalent histologic subtype of vulvar cancer, accounting for the majority of cases. Imaging plays ...

Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ES...
https://doi.org/10.1016/j.annonc.2020.07.011
Annals of Oncology : Official Journal of the European Soc... Machiels JP, René Leemans C et. al.

Nov 26th, 2020 - Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.|2020|Machiels JP,René Leemans C,Golusinski W,Grau C,Licitra L,|diagnosis,epidemiol...

Immunotherapy and Beyond: Treatment Options and Potential Markers in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200227/full/

Jul 2nd, 2020 - Head and neck cancers account for approximately 4% of all cancers in the United States1 and are the eighth most common cancer affecting men in the United States.2 The diagnosis of recurrent or metastatic head and neck squamous cell carcinoma (R/M ...

Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline.
https://doi.org/10.1200/JCO.20.00866
Journal of Clinical Oncology : Official Journal of the Am... Shah MA, Kennedy EB et. al.

Jun 22nd, 2020 - To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with locally advanced esophageal cancer. ASCO convened an Expert Panel to conduct a systematic review of the more recently published litera...

FDA approves nivolumab for esophageal squamous cell carcinoma
https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-nivolumab-esophageal-squamous-cell-carcinoma
FDA

Jun 9th, 2020 - On June 10, 2020, the Food and Drug Administration approved nivolumab (OPDIVO, Bristol-Myers Squibb Co.) for patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and p...

see more →

Drugs  31 results see all →

Clinicaltrials.gov  54,835 results

Squamous Cell Carcinoma of the Head and Neck: Current Status and Future Directions
https://ascopost.com/issues/may-10-2021/squamous-cell-carcinoma-of-the-head-and-neck-current-status-and-future-directions/

May 9th, 2021 - Although head and neck cancers include multiple histologies and primary sites, squamous cell carcinomas (SCC) originating in the oropharynx, oral cavity, larynx, or hypopharynx are the most common. Today, we recognize different types of head and n...

ACR Appropriateness Criteria® Staging and Follow-up of Vulvar Cancer.
https://doi.org/10.1016/j.jacr.2021.02.016
Journal of the American College of Radiology : JACR; , Lakhman Y et. al.

May 7th, 2021 - Vulvar cancer is an uncommon gynecologic tumor and one of several human papillomavirus-associated malignancies. Squamous cell carcinoma is the most prevalent histologic subtype of vulvar cancer, accounting for the majority of cases. Imaging plays ...

Predicting survival in head and neck cancer: External validation and update of the prog...
https://doi.org/10.1002/hed.26716
Head & Neck; Hoesseini A, van Leeuwen N et. al.

May 7th, 2021 - Disclosing prognostic information is necessary to enable patients to make well-informed treatment decisions. OncologIQ is a prognostic model that predicts the overall survival (OS) probability in patients with head and neck squamous cell carcinoma...

Radiomics and gene expression profile to characterise the disease and predict outcome i...
https://doi.org/10.1007/s00259-021-05371-7
European Journal of Nuclear Medicine and Molecular Imaging; Kirienko M, Sollini M et. al.

May 7th, 2021 - The objectives of our study were to assess the association of radiomic and genomic data with histology and patient outcome in non-small cell lung cancer (NSCLC). In this retrospective single-centre observational study, we selected 151 surgically t...

see more →

News  941 results

Fast Five Quiz: Squamous Cell Non-Small Cell Lung Cancer
https://reference.medscape.com/viewarticle/928233

May 4th, 2021 - Lung cancer continues to be the leading cause of cancer-related deaths worldwide. Non–small cell lung cancer (NSCLC), which accounts for 85% of all lung cancers, is divided histologically into adenocarcinoma, squamous cell carcinoma, and large cel...

Fast Five Quiz: Non–Small Cell Lung Cancer Management
https://reference.medscape.com/viewarticle/923235

Feb 2nd, 2021 - Non–small cell lung cancer (NSCLC) accounts for the vast majority of all lung cancers and is a leading cause of death worldwide. Histologically, NSCLC is characterized as adenocarcinoma, squamous cell carcinoma, or large cell carcinoma. A complete...

Expert Offers Tips for Sorting Out Pink Lesions on Dermoscopy
https://www.medscape.com/viewarticle/945115

Feb 1st, 2021 - Even in the most experienced hands, dermoscopy poses a challenge when the usual pigment clues are lacking to help distinguish melanoma from amelanotic melanoma and pigmented basal cell carcinoma (BCC) from nonpigmented BCC. Dr Jennifer Stein "For ...

Gene Test Helps Inform Management of High-Risk SCC Patients
https://www.medscape.com/viewarticle/945044

Jan 31st, 2021 - Emerging data support the clinical validity and use of DecisionDx-SCC as a prognostic 40-gene expression profile test for patients with high-risk squamous cell carcinoma (SCC), according to Anna A. Bar, MD. "The incidence of SCC has been growing r...

SLN Biopsy for Oral Cancer? French Surgeons Say 'Oui'
https://www.medscape.com/viewarticle/940134

Nov 1st, 2020 - French investigators are suggesting that sentinel lymph node (SLN) biopsy should replace neck lymph node dissection as the new standard for detecting occult metastases in patients with T1-T2N0 oral and oropharyngeal squamous cell carcinoma. In a r...

see more →

Patient Education  31 results see all →